jueves, 16 de noviembre de 2023

Selpercatinib Slows Progression of RET-Positive Lung, Medullary Thyroid Cancers

https://www.cancer.gov/news-events/cancer-currents-blog/2023/selpercatinib-ret-lung-medullary-thyroid?cid=eb_govdel

No hay comentarios:

Publicar un comentario